Company news

February 24, 2010
Back to TopE-mailPrintBookmark and Share

The Indianapolis-area claims three of the four healthiest counties in the state, but also some of the laggards, according to a new report by New Jersey-based Robert Wood Johnson Foundation. Hamilton, Hendricks and Boone counties ranked first, second and fourth, respectively. The rankings were based on such things as death rates, insurance rates, socioeconomic factors and environmental influences. However, Marion County ranked 80th out of Indiana’s 92 counties. Shelby and Madison counties also scored poorly, ranking No. 70 and No. 79, respectively.

Most of Indiana’s life sciences business development has occurred in the “golden triangle” that runs from Bloomington to Indianapolis to Lafayette. But the latest investment by BioCrossroads’ Indiana Seed Fund shows some potential for cross-state development that breaks out of that mold. South Bend-based Bioscience Vaccines Inc. has licensed the extracellular matrix technology developed by Cook Biotech in West Lafayette. With scientific help from the University of Notre Dame, Biosciences Vaccine aims to start a clinical trial by year’s end. It hopes that combining Cook Biotech’s extracellular matrix with vaccines against tetanus and prostate cancer will prove more effective than traditional delivery of the medicines. BioCrossroads will commit $400,000 to help the company’s research.

Indianapolis-based Vortek Surgical LLC will relocate to Brownsburg, expanding its headquarters, manufacturing and distribution operations and creating more than 60 life sciences jobs in the next three years. Founded in 2006, the company expects to launch a consumer subsidiary in the second quarter to focus on health care products. It plans to begin hiring employees for both the consumer and medical product divisions beginning in April. Vortek develops and markets medical devices designed to reduce the risk of hospital infections during surgery.

Indianapolis-based Marcadia Biotech Inc. has launched a Phase 1 clinical trial of its experimental anti-diabetes drug MAR701. The drug mimics the action of two hormones, glucagon-like peptide and gastric inhibitory peptide. Those proteins both boost the body’s production of insulin, which is necessary to fight diabetes. Marcadia hopes to market the drug as a once-a-week medicine to treat Type 2 diabetes.


Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. If I were a developer I would be looking at the Fountain Square and Fletcher Place neighborhoods instead of Broad Ripple. I would avoid the dysfunctional BRVA with all of their headaches. It's like deciding between a Blackberry or an iPhone 5s smartphone. BR is greatly in need of updates. It has become stale and outdated. Whereas Fountain Square, Fletcher Place and Mass Ave have become the "new" Broad Ripples. Every time I see people on the strip in BR on the weekend I want to ask them, "How is it you are not familiar with Fountain Square or Mass Ave? You have choices and you choose BR?" Long vacant storefronts like the old Scholar's Inn Bake House and ZA, both on prominent corners, hurt the village's image. Many business on the strip could use updated facades. Cigarette butt covered sidewalks and graffiti covered walls don't help either. The whole strip just looks like it needs to be power washed. I know there is more to the BRV than the 700-1100 blocks of Broad Ripple Ave, but that is what people see when they think of BR. It will always be a nice place live, but is quickly becoming a not-so-nice place to visit.

  2. I sure hope so and would gladly join a law suit against them. They flat out rob people and their little punk scam artist telephone losers actually enjoy it. I would love to run into one of them some day!!

  3. Biggest scam ever!! Took 307 out of my bank ac count. Never received a single call! They prey on new small business and flat out rob them! Do not sign up with these thieves. I filed a complaint with the ftc. I suggest doing the same ic they robbed you too.

  4. Woohoo! We're #200!!! Absolutely disgusting. Bring on the congestion. Indianapolis NEEDS it.

  5. So Westfield invested about $30M in developing Grand Park and attendance to date is good enough that local hotel can't meet the demand. Carmel invested $180M in the Palladium - which generates zero hotel demand for its casino acts. Which Mayor made the better decision?